Oligometastatic Disease at Presentation or Recurrence for Nonsmall Cell Lung Cancer
Joint Authors
Niibe, Yuzuru
Gomez, Daniel R.
Chang, Joe Y.
Source
Issue
Vol. 2012, Issue 2012 (31 Dec. 2012), pp.1-6, 6 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2012-07-30
Country of Publication
Egypt
No. of Pages
6
Main Subjects
Abstract EN
Oligometastatic Non-Small Cell Lung Cancer (NSCLC) presents a unique opportunity for potential curative therapy.
Improved cancer staging using PET/CT, MRI, and future cellular and molecular staging with circulating tumor cells and/or molecular markers will identify more patients with truly oligometastasis disease that will benefit from definitive local treatment.
Recent development of noninvasive local ablative therapy such as stereotactic radiotherapy makes it possible to eradicate multiple local diseases with minimal side effect.
Novel systemic therapy may also control systemic spread and therefore make it possible to improve survival by eliminating local diseases.
More research, particularly prospective studies, is ideally randomized studies are needed to validate the concept of oligometastasis.
American Psychological Association (APA)
Gomez, Daniel R.& Niibe, Yuzuru& Chang, Joe Y.. 2012. Oligometastatic Disease at Presentation or Recurrence for Nonsmall Cell Lung Cancer. Pulmonary Medicine،Vol. 2012, no. 2012, pp.1-6.
https://search.emarefa.net/detail/BIM-468861
Modern Language Association (MLA)
Gomez, Daniel R.…[et al.]. Oligometastatic Disease at Presentation or Recurrence for Nonsmall Cell Lung Cancer. Pulmonary Medicine No. 2012 (2012), pp.1-6.
https://search.emarefa.net/detail/BIM-468861
American Medical Association (AMA)
Gomez, Daniel R.& Niibe, Yuzuru& Chang, Joe Y.. Oligometastatic Disease at Presentation or Recurrence for Nonsmall Cell Lung Cancer. Pulmonary Medicine. 2012. Vol. 2012, no. 2012, pp.1-6.
https://search.emarefa.net/detail/BIM-468861
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-468861